The Prevalence and Diagnostic Utility of Binding, Blocking, and Modulating Antibodies in Ocular Myasthenia

Update Item Information
Identifier 20200310_nanos_posters_259
Title The Prevalence and Diagnostic Utility of Binding, Blocking, and Modulating Antibodies in Ocular Myasthenia
Creator Samia Nawaz; Joseph Chacko
Affiliation (SN) (JC) University of Arkansas for Medical Sciences, Little Rock, AR
Subject Myasthenia; Ocular Motility; Neuro-ophthalmology & Systemic Disease (eg. MS, MG, Thyroid); Diagnostic Tests (ERG, VER, OCT, HRT, mfERG, etc); Eyelid & Adnexal Disease; Miscellaneous
Description Myasthenia gravis (MG) is characterized by the presence of auto-antibodies against the acetylcholine receptor (AChR). One can test for several types of AChR antibodies to make a successful MG diagnosis. This study aimed to examine whether antibody testing can be streamlined to what is crucial for diagnosis and whether prednisone and/or pyridostigmine were correlated with conversion from ocular to systemic MG.
Date 2020-03
Language eng
Format application/pdf
Type Text
Source 2020 North American Neuro-Ophthalmology Society Annual Meeting
Relation is Part of NANOS Annual Meeting 2020: Poster Session II: Scientific Advancements
Collection Neuro-ophthalmology Virtual Education Library: NOVEL http://NOVEL.utah.edu
Publisher Spencer S. Eccles Health Sciences Library, University of Utah
Holding Institution North American Neuro-Ophthalmology Association. NANOS Executive Office 5841 Cedar Lake Road, Suite 204, Minneapolis, MN 55416
Rights Management Copyright 2020. For further information regarding the rights to this collection, please visit: https://NOVEL.utah.edu/about/copyright
ARK ark:/87278/s63r63dx
Context URL The NANOS Annual Meeting Neuro-Ophthalmology Collection: https://novel.utah.edu/collection/NAM/toc/
Setname ehsl_novel_nam
ID 1542126
Reference URL https://collections.lib.utah.edu/ark:/87278/s63r63dx